Circular RNA circPFKP suppress gastric cancer progression through targeting miR-346/CAMD3 axis

Xin Song1, Guochao Zhang1, Jinwei Niu1

  • 1General Surgery department, China-Japan Friendship Hospital, 2 Yinghua East Street, Chaoyang District, Beijing, 100029, PR China.

PubMed

Insights

Circular RNAs (circRNAs) regulate tumor development. This study found circPFKP inhibits gastric cancer progression by targeting the miR-346/CAMD3 pathway, offering a potential diagnostic and therapeutic biomarker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) play a role in tumor pathogenesis, but their specific function in gastric cancer (GC) remains unclear.
  • Gastric cancer is a significant global health concern, necessitating further research into its underlying molecular mechanisms.

Purpose of the Study:

  • To investigate the role and mechanism of circPFKP in gastric cancer.
  • To identify potential diagnostic and therapeutic targets for GC.

Main Methods:

  • Differential expression analysis of circRNAs using gene chips (GSE93541, GSE89143, GSE78092).
  • Quantitative real-time polymerase chain reaction (qRT-PCR) for gene expression analysis.
  • In vitro (CCK-8, Transwell assays) and in vivo (mice xenograft assay) functional studies.
  • Bioinformatics, dual-luciferase reporter, and RNA pull-down assays to confirm molecular interactions.

Main Results:

  • circPFKP was found to be downregulated in GC tissues and cells.
  • Overexpression of circPFKP suppressed GC cell proliferation, migration, invasion, and tumor growth in vivo.
  • circPFKP functions as a molecular sponge for miR-346, thereby regulating CAMD3 expression.
  • Upregulation of CAMD3 or inhibition of miR-346 reversed the anti-cancer effects of circPFKP.

Conclusions:

  • circPFKP inhibits gastric cancer progression through the miR-346/CAMD3 axis.
  • circPFKP represents a potential novel biomarker for GC diagnosis and treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K